RAMSAY GENERALE DE SANTE : availability of DEU on 30 June 2019

NEXT STORY
Merus Announces Pricing of Public Offering of Common Shares
PREV STORY
Presentations at ASN Kidney Week 2019 Highlight Breadth of ChemoCentryx Platform in Treatment of Complement 3 Glomerulopathy (C3G) and Focal Segmental Glomerulosclerosis (FSGS)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Saudi Arabia In-Vitro Diagnostics (IVD) Markets to 2024

author_avatar
NASDAQ Market News

Primary endpoint met in COMET-TAIL Phase 3 trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19

author_avatar
NASDAQ Market News

Crinetics Pharmaceuticals Announces Upcoming Presentations at ENDO2019

author_avatar
NASDAQ Market News